Technologies

Medical Sciences

Title:

Biomarker for Rheumatic Heart Disease (RHD)- Prototype is Ready for Commercialization

Area:

Medical Sciences

Focus Area:

Rheumatic Heart Disease

Patent:

IN319303, ZA201302538

Social Benefits:

Measrement of clinical activityin RHD, prognosis and overall management of rhheumatic heart disease.

Developing Agency:

CSIR-Indian Institute of Chemical Biology (IICB), West Bengal

Technology Readiness Index:

Lab Validation

Email:

director@iicb.res.in
Website Link :http://www.iicb.res.in
Source (more info) :https://t.ly/l_sb

Brief Description

Description :

It is a protein based biomarker, it is detected in serum and urine, This test kit would help measurement of clinical activity in quiescent rheumatic heart disease, post penicillin treatment and overall management of the disease.

Related Technologies